Cation Exchange Chromatography Media for Antibody Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cation exchange chromatography media are inadequate for efficiently separating antibody monomers from aggregates in antibody drug manufacturing processes, leading to impurities and reduced antigen recognition ability, with existing methods facing challenges in high adsorption capacity and high flow rate performance.
Innovation Solution
A cation exchange chromatography media is developed by polymerizing a monomer containing at least one sulfone group, bonded to porous particles, specifically using a copolymer of 2-acrylamide-2-methylpropanesulfonic acid with neutral or weak cation monomers, providing high antibody adsorptivity and efficient separation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional cation exchange chromatography media are used, then antibody aggregates can be eliminated, but the adsorption capacity is low and separation efficiency is insufficient
Solution Approach 1:
The patent changes the chemical parameters of the chromatography media by incorporating specific sulfonic acid groups and controlling the crosslinking degree (5-20%) to optimize both adsorption capacity and separation efficiency for antibody purification
Solution Approach 2:
The patent creates composite chromatography media by combining porous particles with specific polymer matrices containing sulfonic acid groups, achieving enhanced performance for separating antibody monomers from aggregates
2Productivity
If high adsorption capacity is achieved, then productivity increases, but the media may not maintain performance at high flow rates
Solution Approach 1:
The patent utilizes porous particles as the base media with optimized pore structures that allow high adsorption capacity while maintaining excellent flow rate performance, enabling efficient antibody purification at high speeds
Solution Approach 2:
The patent optimizes physical parameters including pore size, crosslinking degree, and particle density to achieve a balance between high adsorption capacity and high flow rate performance
3Quantity of substance
If protein A chromatography is used for initial purification, then antibody is captured efficiently, but antibody aggregates are not effectively separated
Solution Approach 1:
The patent employs a segmented purification approach where protein A chromatography performs initial antibody capture, followed by cation exchange chromatography with the specialized media for aggregate separation, dividing the purification process into functional stages
Solution Approach 2:
The patent introduces a specialized cation exchange media as an intermediary step between protein A chromatography and final product formulation, enabling effective aggregate removal while preserving antibody activity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The media enables high-purity separation of antibody monomers from aggregates, achieving high dynamic binding capacity and efficient separation performance, suitable for antibody drug manufacturing processes.
Implementation Method 1
separation of an antibody monomer from aggregates thereof using a chromatography media having a mixed mode ligand... a separation method utilizing an electrostatic interaction in ion exchange chromatography
Implementation Method 2
cation exchange chromatography media for purifying of an antibody... structure formed by bonding a base media containing porous particles with a copolymer composed of a strong cation monomer unit... ion exchange capacity
Data Source
Figure 1
Figure 2
AI summary
To provide a cation exchange chromatography media that can be preferably used for purifying of an antibody drug, particularly, a cation exchange chromatography media having satisfactory performance of separation of an antibody monomer from a aggregates thereof to be produced in an antibody drug manufacturing process. The cation exchange chromatography media for purifying of the antibody comprises a base media involving porous particles and a polymer containing, in the range of 30 to 100 mol% based on the total monomer, at least one kind of strong cation exchange monomer unit represented by formula (1) or formula (2), and ion exchange capacity of the cation exchange chromatography media is from 60 to 300 µmol/mL: (wherein, R1, R2 and R3 are each independently a hydrogen atom or methyl, A1 and A2 are -R4-SO3M, here, R4 is alkylene having 2 to 4 carbons, and M is a hydrogen atom, Na or K.)